Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Nurix Therapeutics, Inc. net margin for the quarter ending 2026-05-31 was -990.10%, a change of -891.45% year-over-year.
Nurix Therapeutics, Inc. net margin for the quarter ending 2026-02-28 was -1394.34%, a change of -1088.96% year-over-year.
Nurix Therapeutics, Inc. net margin for the quarter ending 2025-11-30 was -576.13%, a change of -135.38% year-over-year.
Nurix Therapeutics, Inc. net margin for the quarter ending 2025-08-31 was -1094.77%, a change of -705.86% year-over-year.
Nurix Therapeutics, Inc. net margin for fiscal 2025 was -314.90%, a change of 39.95% from fiscal 2024.
Nurix Therapeutics, Inc. net margin for fiscal 2024 was -354.85%, a change of -167.88% from fiscal 2023.
Nurix Therapeutics, Inc. net margin for fiscal 2023 was -186.98%, a change of 279.95% from fiscal 2022.
Nurix Therapeutics, Inc. net margin for fiscal 2022 was -466.93%, a change of -73.00% from fiscal 2021.